BRFSS Asthma Call-back Survey Prevalence TABLE 9

TABLE 9. Estimated percent using an inhaled corticosteroid in the past 3 months among adults1 Click here to skip to citation 1 with current2 Click here to skip to citation 2 or active3 Click here to skip to citation 3 asthma status by state/territory - BRFSS Asthma Call-back Survey, United States, 2009
State/Territory Current Active
Sample
size±
% SE§ 95% CI Sample
size
% SE 95% CI
Arizona 113 34.6 7.4 (20.1 - 49.1) 118 35.2 7.3 (20.9 - 49.5)
California 517 35.2 3.3 (28.7 - 41.7) 549 32.3 3.2 (26.0 - 38.6)
Connecticut 235 30.5 4.2 (22.3 - 38.7) 257 29.0 4.0 (21.2 - 36.8)
District of Columbia 134 25.9 4.6 (16.9 - 34.9) 151 24.2 4.2 (16.0 - 32.4)
Florida 416 26.7 3.5 (19.8 - 33.6) 454 23.2 3.4 (16.5 - 29.9)
Georgia 192 30.5 4.9 (20.9 - 40.1) 198 26.7 4.7 (17.5 - 35.9)
Hawaii 278 40.9 4.9 (31.3 - 50.5) 275 42.7 4.9 (33.1 - 52.3)
Illinois 185 39.6 5.1 (29.6 - 49.6) 204 36.3 4.8 (26.9 - 45.7)
Indiana 391 29.6 3.5 (22.7 - 36.5) 426 27.6 3.3 (21.1 - 34.1)
Iowa 233 30.6 4.3 (22.2 - 39.0) 247 28.3 4.1 (20.3 - 36.3)
Kansas 828 32.6 2.5 (27.7 - 37.5) 885 32.4 2.5 (27.5 - 37.3)
Louisiana 196 32.9 5.5 (22.1 - 43.7) 218 30.0 4.9 (20.4 - 39.6)
Maine 235 27.9 3.7 (20.6 - 35.2) 254 26.9 3.4 (20.2 - 33.6)
Maryland 267 28.6 3.9 (21.0 - 36.2) 289 27.3 3.6 (20.2 - 34.4)
Massachusetts 225 44.0 5.7 (32.8 - 55.2) 252 38.7 5.1 (28.7 - 48.7)
Michigan 471 38.4 3.3 (31.9 - 44.9) 531 33.9 2.9 (28.2 - 39.6)
Montana 307 33.1 4.3 (24.7 - 41.5) 318 34.7 4.2 (26.5 - 42.9)
Nebraska 540 32.8 3.8 (25.4 - 40.2) 548 33.8 3.8 (26.4 - 41.2)
Nevada 131 36.6 9.5 (18.0 - 55.2) 139 34.0 9.0 (16.4 - 51.6)
New Hampshire 259 44.7 4.8 (35.3 - 54.1) 283 39.8 4.5 (31.0 - 48.6)
New Jersey 360 28.0 3.6 (20.9 - 35.1) 392 25.5 3.2 (19.2 - 31.8)
New Mexico 205 44.1 5.0 (34.3 - 53.9) 226 39.4 4.8 (30.0 - 48.8)
New York 326 40.9 5.0 (31.1 - 50.7) 357 38.1 4.8 (28.7 - 47.5)
North Dakota 190 37.0 4.9 (27.4 - 46.6) 200 37.7 4.7 (28.5 - 46.9)
Ohio 276 23.8 3.5 (16.9 - 30.7) 299 22.8 3.3 (16.3 - 29.3)
Oklahoma 283 28.1 3.8 (20.7 - 35.5) 293 27.3 3.7 (20.0 - 34.6)
Oregon 149 42.5 5.9 (30.9 - 54.1) 164 38.6 5.4 (28.0 - 49.2)
Rhode Island 302 32.3 3.9 (24.7 - 39.9) 326 29.2 3.6 (22.1 - 36.3)
Texas 472 31.5 3.8 (24.1 - 38.9) 505 26.8 3.4 (20.1 - 33.5)
Utah 433 27.9 2.8 (22.4 - 33.4) 481 25.6 2.6 (20.5 - 30.7)
Vermont 360 37.2 4.5 (28.4 - 46.0) 385 36.4 4.3 (28.0 - 44.8)
Virginia 183 20.7 4.1 (12.7 - 28.7) 189 20.0 4.0 (12.2 - 27.8)
Washington 491 38.6 3.9 (31.0 - 46.2) 533 35.4 3.6 (28.3 - 42.5)
West Virginia 248 35.0 4.5 (26.2 - 43.8) 257 34.6 4.4 (26.0 - 43.2)
Wisconsin 223 48.8 5.9 (37.2 - 60.4) 235 46.5 5.7 (35.3 - 57.7)
Puerto Rico 165 23.2 4.7 (14.0 - 32.4) 245 17.6 3.4 (10.9 - 24.3)
36 state total 10,819 34.0 1.0 (32.0 - 36.0) 11,683 31.1 1.0 (29.1 - 33.1)
Median   32.9       32.4    
Range   20.7-48.8       17.6-46.5    

1 Aged ≥ 18 years

2 "Yes" response to "Do you still have asthma?"

3 Reported any of the following during the past year: asthma medication use, asthma symptoms, or MD visits for asthma

± Sample size excludes "DK/Refused"

§ Standard error

Confidence interval